Department of Orthopaedic Surgery and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.
College of Earth and Environmental Sciences, School of Public Health, Lanzhou University, Lanzhou, China.
Orthop Surg. 2021 May;13(3):692-700. doi: 10.1111/os.12969. Epub 2021 Mar 7.
The diagnostic potential of D-dimer and fibrinogen to detect periprosthetic joint infection (PJI) of the hip and knee is not well-understood. The aim of this study was to determine whether D-Dimer and fibrinogen can be used as effective biomarkers to screen PJI. A systematic review of the literature indexed in Web of Science, PubMed, Cochrane Library, Embase, and Google Scholar databases was performed. All studies using D-dimer levels in serum or plasma, or fibrinogen levels in plasma, for the diagnosis of PJI were included. Meta-analysis estimates, including sensitivity, specificity, diagnostic odds ratios (DOR), and the area under the summary receiver operating characteristic curve (AUSROC), were calculated using a random-effects model, and used to assess the diagnostic accuracy of these biomarkers. A total of nine studies were analyzed, and their quality was considered to be acceptable. D-dimer gave a limited diagnostic value if serum and plasma combined: sensitivity (0.77, 95% confidence interval [CI] [0.63 to 0.87]), specificity (0.67, 95% CI [0.54 to 0.78]), DOR (6.81, 95% CI [2.67 to 17.37]), and AUSROC (0.78, 95% CI [0.74 to 0.82]). Plasma D-dimer levels were associated with less satisfactory sensitivity (0.65, 95% CI 0.57 to 0.71), specificity (0.58, 95% CI 0.50 to 0.66), DOR (2.52, 95% CI 1.64 to 3.90), and AUSROC (0.65, 95% CI 0.61 to 0.69). Serum D-dimer levels showed higher corresponding values of 0.89 (95% CI 0.79 to 0.94), 0.76 (95% CI 0.55 to 0.89), 24.24 (95% CI 10.07 to 58.32), and 0.91 (95% CI 0.88 to 0.93). Plasma fibrinogen showed acceptable corresponding values of 0.79 (95% CI 0.70 to 0.85), 0.73 (95% CI 0.57 to 0.85), 10.14 (95% CI 6.16 to 16.70), and 0.83 (95% CI 0.79 to 0.86). Serum D-dimer may be an effective marker for the diagnosis of PJI in hip and knee arthroplasty patients, and it may show higher diagnostic potential than plasma fibrinogen. Plasma D-dimer may have limited diagnostic potential.
D-二聚体和纤维蛋白原诊断髋关节和膝关节假体周围关节感染(PJI)的潜力尚未被充分了解。本研究旨在确定 D-二聚体和纤维蛋白原是否可作为有效的生物标志物来筛查 PJI。我们对 Web of Science、PubMed、Cochrane Library、Embase 和 Google Scholar 数据库中索引的文献进行了系统回顾。纳入了所有使用血清或血浆中的 D-二聚体水平或血浆中的纤维蛋白原水平来诊断 PJI 的研究。使用随机效应模型计算了包括敏感度、特异度、诊断比值比(DOR)和汇总受试者工作特征曲线下面积(AUSROC)在内的荟萃分析估计值,并用于评估这些生物标志物的诊断准确性。共分析了 9 项研究,其质量被认为是可以接受的。如果将血清和血浆结合使用,D-二聚体的诊断价值有限:敏感度(0.77,95%置信区间[CI] [0.63 至 0.87])、特异度(0.67,95%CI [0.54 至 0.78])、DOR(6.81,95%CI [2.67 至 17.37])和 AUSROC(0.78,95%CI [0.74 至 0.82])。血浆 D-二聚体水平与较低的敏感度(0.65,95%CI 0.57 至 0.71)、特异度(0.58,95%CI 0.50 至 0.66)、DOR(2.52,95%CI 1.64 至 3.90)和 AUSROC(0.65,95%CI 0.61 至 0.69)相关。血清 D-二聚体水平的相应值更高,分别为 0.89(95%CI 0.79 至 0.94)、0.76(95%CI 0.55 至 0.89)、24.24(95%CI 10.07 至 58.32)和 0.91(95%CI 0.88 至 0.93)。血浆纤维蛋白原的相应值为 0.79(95%CI 0.70 至 0.85)、0.73(95%CI 0.57 至 0.85)、10.14(95%CI 6.16 至 16.70)和 0.83(95%CI 0.79 至 0.86)。血清 D-二聚体可能是髋关节和膝关节置换术患者 PJI 的有效诊断标志物,其诊断潜力可能高于血浆纤维蛋白原。血浆 D-二聚体可能具有有限的诊断潜力。